These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32742934)

  • 1. Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: Results from a survey with 228 patients and their caregivers.
    Martins AM; Pessoa ALS; Quesada AA; Ribeiro EM
    Mol Genet Metab Rep; 2020 Sep; 24():100624. PubMed ID: 32742934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry.
    Kenneson A; Singh RH
    Mol Genet Metab; 2021 Nov; 134(3):243-249. PubMed ID: 34654619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic etiology and clinical challenges of phenylketonuria.
    Elhawary NA; AlJahdali IA; Abumansour IS; Elhawary EN; Gaboon N; Dandini M; Madkhali A; Alosaimi W; Alzahrani A; Aljohani F; Melibary EM; Kensara OA
    Hum Genomics; 2022 Jul; 16(1):22. PubMed ID: 35854334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Starting the conversation on gene therapy for phenylketonuria: Current perspectives of patients, caregivers, and advocates.
    Regier DS; Bąk A; Bausell H; O'Reilly E; Cowsert LM
    Mol Genet Metab Rep; 2022 Jun; 31():100855. PubMed ID: 35782620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylketonuria (PKU): A problem solved?
    Brown CS; Lichter-Konecki U
    Mol Genet Metab Rep; 2016 Mar; 6():8-12. PubMed ID: 27014571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up.
    Burton BK; Longo N; Vockley J; Grange DK; Harding CO; Decker C; Li M; Lau K; Rosen O; Larimore K; Thomas J;
    Mol Genet Metab; 2020 Aug; 130(4):239-246. PubMed ID: 32593547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal phenylalanine wash-out in phenylketonuria.
    Porta F; Ponzone A; Spada M
    Metab Brain Dis; 2020 Oct; 35(7):1225-1229. PubMed ID: 32661828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM).
    Thomas J; Levy H; Amato S; Vockley J; Zori R; Dimmock D; Harding CO; Bilder DA; Weng HH; Olbertz J; Merilainen M; Jiang J; Larimore K; Gupta S; Gu Z; Northrup H;
    Mol Genet Metab; 2018 May; 124(1):27-38. PubMed ID: 29653686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic phenotyping in phenylketonuria reveals disease clustering independently of metabolic control.
    Moritz L; Klotz K; Grünert SC; Hannibal L; Spiekerkoetter U
    Mol Genet Metab; 2023 Mar; 138(3):107509. PubMed ID: 36791482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of phenylketonuria in adult patients in Italy: a survey of six specialist metabolic centers.
    Burlina A; Leuzzi V; Spada M; Carbone MT; Paci S; Tummolo A
    Curr Med Res Opin; 2021 Mar; 37(3):411-421. PubMed ID: 33222540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria.
    Zori R; Thomas JA; Shur N; Rizzo WB; Decker C; Rosen O; Li M; Schweighardt B; Larimore K; Longo N
    Mol Genet Metab; 2018 Nov; 125(3):217-227. PubMed ID: 30146451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylketonuria: translating research into novel therapies.
    Ho G; Christodoulou J
    Transl Pediatr; 2014 Apr; 3(2):49-62. PubMed ID: 26835324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Phenylketonuria Disease in Jordan: Medical and Nutritional Challenges.
    Dababneh S; Alsbou M; Taani N; Sharkas G; Ismael R; Maraqa L; Nemri O; Al-Jawaldeh H; Kopti N; Atieh E; Almasri A
    Children (Basel); 2022 Mar; 9(3):. PubMed ID: 35327772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The personal burden for caregivers of children with phenylketonuria: A cross-sectional study investigating time burden and costs in the UK.
    MacDonald A; Smith TA; de Silva S; Alam V; van Loon JM
    Mol Genet Metab Rep; 2016 Dec; 9():1-5. PubMed ID: 27622144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylketonuria: an inborn error of phenylalanine metabolism.
    Williams RA; Mamotte CD; Burnett JR
    Clin Biochem Rev; 2008 Feb; 29(1):31-41. PubMed ID: 18566668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria.
    Zori R; Ahring K; Burton B; Pastores GM; Rutsch F; Jha A; Jurecki E; Rowell R; Harding C
    Mol Genet Metab; 2019; 128(1-2):92-101. PubMed ID: 31439512
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.